Literature DB >> 25217149

Impact of de-escalation on ICU patients' prognosis.

Jan J De Waele1, Matteo Bassetti, Ignacio Martin-Loeches.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25217149     DOI： 10.1007/s00134-014-3488-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  10 in total

1.  De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

Authors:  J Garnacho-Montero; A Gutiérrez-Pizarraya; A Escoresca-Ortega; Y Corcia-Palomo; Esperanza Fernández-Delgado; I Herrera-Melero; C Ortiz-Leyba; J A Márquez-Vácaro
Journal:  Intensive Care Med       Date:  2013-09-12       Impact factor: 17.440

2.  Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.

Authors:  Marin H Kollef; Lee E Morrow; Michael S Niederman; Kenneth V Leeper; Antonio Anzueto; Lisa Benz-Scott; Frank J Rodino
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

3.  Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?

Authors:  Sarah Heenen; Frédérique Jacobs; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2012-05       Impact factor: 7.598

Review 4.  Risks for multidrug-resistant pathogens in the ICU.

Authors:  Ignacio Martín-Loeches; Emili Diaz; Jordi Vallés
Journal:  Curr Opin Crit Care       Date:  2014-10       Impact factor: 3.687

5.  De-escalation therapy in ventilator-associated pneumonia.

Authors:  Jordi Rello; Loreto Vidaur; Alberto Sandiumenge; Alejandro Rodríguez; Belen Gualis; Carmen Boque; Emili Diaz
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

6.  De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.

Authors:  Marc Leone; Carole Bechis; Karine Baumstarck; Jean-Yves Lefrant; Jacques Albanèse; Samir Jaber; Alain Lepape; Jean-Michel Constantin; Laurent Papazian; Nicolas Bruder; Bernard Allaouchiche; Karine Bézulier; François Antonini; Julien Textoris; Claude Martin
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

7.  De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.

Authors:  Djamel Mokart; Géraldine Slehofer; Jérôme Lambert; Antoine Sannini; Laurent Chow-Chine; Jean-Paul Brun; Pierre Berger; Ségolène Duran; Marion Faucher; Jean-Louis Blache; Colombe Saillard; Norbert Vey; Marc Leone
Journal:  Intensive Care Med       Date:  2014-01       Impact factor: 17.440

8.  De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality?

Authors:  Jan J De Waele; Mariska Ravyts; Pieter Depuydt; Stijn I Blot; Johan Decruyenaere; Dirk Vogelaers
Journal:  J Crit Care       Date:  2010-01-15       Impact factor: 3.425

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units.

Authors:  Philippe Montravers; Hervé Dupont; Rémy Gauzit; Benoit Veber; Jean-Pierre Bedos; Alain Lepape
Journal:  Crit Care       Date:  2011-01-13       Impact factor: 9.097
  10 in total
  5 in total

1.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

Review 2.  Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Authors:  Werner C Albrich; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2015-07-21       Impact factor: 17.440

3.  A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients.

Authors:  Mieke Carlier; Jason A Roberts; Veronique Stove; Alain G Verstraete; Jeffrey Lipman; Jan J De Waele
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin.

Authors:  Rong Fu; Tong Chen; Jia Song; Guojin Wang; Lijuan Li; Erbao Ruan; Hui Liu; Yihao Wang; Huaquan Wang; Limin Xing; Yuhong Wu; Hong Liu; Wen Qu; Zonghong Shao
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 5.  Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.

Authors:  Matteo Bassetti; Jan J De Waele; Philippe Eggimann; Josè Garnacho-Montero; Gunnar Kahlmeter; Francesco Menichetti; David P Nicolau; Jose Arturo Paiva; Mario Tumbarello; Tobias Welte; Mark Wilcox; Jean Ralph Zahar; Garyphallia Poulakou
Journal:  Intensive Care Med       Date:  2015-03-20       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.